Works matching IS 17534658 AND DT 2015 AND VI 9 AND IP 3
Results: 5
Nintedanib in the treatment of idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 121, doi. 10.1177/1753465815579365
- By:
- Publication type:
- Article
Targeting the immune system to treat lung cancer: rationale and clinical experience.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 105, doi. 10.1177/1753465815578349
- By:
- Publication type:
- Article
The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 97, doi. 10.1177/1753465815577738
- By:
- Publication type:
- Article
Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 84, doi. 10.1177/1753465815576471
- By:
- Publication type:
- Article
Limiting volume with modern ventilators.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 75, doi. 10.1177/1753465815576439
- By:
- Publication type:
- Article